Last reviewed · How we verify
RANITIDINE BISMUTH CITRATE
RANITIDINE BISMUTH CITRATE is a drug. It is currently FDA-approved (first approved 1996).
Ranitidine bismuth citrate is a small molecule that acts as a histamine H2 receptor antagonist. It has been studied in various clinical trials for conditions such as laryngopharyngeal reflux and arthritis knee, among others.
At a glance
| Generic name | RANITIDINE BISMUTH CITRATE |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 1996 |
Approved indications
Common side effects
Key clinical trials
- Study of the Interest of Pursuing or Not the Chemotherapy for Patients With Metastatic Esophageal Cancer (PHASE2)
- Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies (PHASE1)
- Effect of Dexmedetomidine on the Quality of Recovery in Parturients Undergoing Elective Caesarean Sections (PHASE4)
- A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMT (PHASE3)
- : Vascular Function in Health and Disease (PHASE1)
- Safety, Pharmacokinetics, and Preliminary Efficacy of Isatuximab in Patients Awaiting Kidney Transplantation (PHASE1, PHASE2)
- Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel (PHASE2, PHASE3)
- Effect of H2 Receptor Antagonist and Proton Pump Inhibitor on the Positivity Rates and Clinical Outcomes of COVID-19
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- RANITIDINE BISMUTH CITRATE CI brief — competitive landscape report
- RANITIDINE BISMUTH CITRATE updates RSS · CI watch RSS
Frequently asked questions about RANITIDINE BISMUTH CITRATE
What is RANITIDINE BISMUTH CITRATE?
When was RANITIDINE BISMUTH CITRATE approved?
What development phase is RANITIDINE BISMUTH CITRATE in?
Related
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing